Literature DB >> 26872992

Non-muscle myosin light chain promotes endothelial progenitor cells senescence and dysfunction in pulmonary hypertensive rats through up-regulation of NADPH oxidase.

Bin Liu1, Tao Li2, Jing-Jie Peng3, Jie-Jie Zhang4, Wei-Qi Liu5, Xiu-Ju Luo6, Qi-Lin Ma5, Zhi-Cheng Gong7, Jun Peng8.   

Abstract

Non-muscle myosin regulatory light chain (nmMLC20) is reported to exert transcriptional function in regulation of gene expression, and NADPH oxidase (NOX)-derived reactive oxygen species contribute to vascular remodeling of pulmonary artery hypertension (PAH). This study aims to determine if nmMLC20 can promote endothelial progenitor cells (EPCs) senescence and dysfunction through up-regulation of NOX in PAH rats. The rats were exposed to10% hypoxia for 3 weeks to establish a PAH model, which showed an increase in right ventricle systolic pressure, right ventricular and pulmonary vascular remodeling, and the accelerated senescence and impaired functions in EPCs, accompanied by an increase in Rho-kinase (ROCK) and NOX activities, p-nmMLC20 level, NOX expression and H2O2 content; these phenomena were reversed by fasudil, a selective inhibitor of ROCK. Next, normal EPCs were cultured under hypoxia to induce senescence in vitro. Consistent with the in vivo findings, hypoxia increased the senescence and dysfunction of EPCs concomitant with an increase in ROCK and NOX activities, p-nmMLC20 level, NOX expression and H2O2 content; these phenomena were reversed by fasudil. Knockdown of nmMLC20 showed similar results to that of fasudil except no effect on ROCK activity. Based on these observations, we conclude that nmMLC20 could promote the senescence and dysfunctions of EPCs in PAH through up-regulation of NOX in a phosphorylation-dependent manner.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Endothelial progenitor cell (EPC); NAPDH oxidase; Non-muscle myosin regulatory light chain (nmMLC(20)); Pulmonary arterial hypertension; Senescence

Mesh:

Substances:

Year:  2016        PMID: 26872992     DOI: 10.1016/j.ejphar.2016.02.022

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

Review 1.  NADPH oxidase: its potential role in promotion of pulmonary arterial hypertension.

Authors:  Jing-Jie Peng; Bin Liu; Jin-Yun Xu; Jun Peng; Xiu-Ju Luo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-11       Impact factor: 3.000

2.  Iptakalim ameliorates hypoxia-impaired human endothelial colony-forming cells proliferation, migration, and angiogenesis via Akt/eNOS pathways.

Authors:  Mengyu He; Ting Cui; Qing Cai; Hong Wang; Hui Kong; Weiping Xie
Journal:  Pulm Circ       Date:  2019-10-18       Impact factor: 3.017

Review 3.  The Role of Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Lung Architecture Remodeling.

Authors:  Anantha Harijith; Viswanathan Natarajan; Panfeng Fu
Journal:  Antioxidants (Basel)       Date:  2017-12-19

4.  Effect of Aldosterone on Senescence and Proliferation Inhibition of Endothelial Progenitor Cells Induced by Sirtuin 1 (SIRT1) in Pulmonary Arterial Hypertension.

Authors:  Yue Wang; Bin Zhong; Qiyong Wu; Jichun Tong; Tao Zhu; Ming Zhang
Journal:  Med Sci Monit       Date:  2020-04-18

5.  Correlation between NADPH oxidase-mediated oxidative stress and dysfunction of endothelial progenitor cell in hyperlipidemic patients.

Authors:  Ting-Bo Li; Yin-Zhuang Zhang; Wei-Qi Liu; Jie-Jie Zhang; Jun Peng; Xiu-Ju Luo; Qi-Lin Ma
Journal:  Korean J Intern Med       Date:  2017-09-13       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.